| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |